AI assistant
BBGI Global Infrastructure S.A. — Director's Dealing 2020
May 20, 2020
5220_dirs_2020-05-20_dc48331b-3434-4e70-88b1-787075205021.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 4090N
BBGI SICAV S.A.
20 May 2020
20 May 2020
BBGI SICAV S.A.
(the "Company")
Director / PDMR Shareholding
The Company was notified on 19 May 2020 of the following transactions by Duncan Ball and Frank Schramm, Co-CEOs of the Company (together, the "Co-CEOs").
· On 19 May 2020, Duncan Ball sold 250,000 ordinary shares in the Company ("Ordinary Shares") at an average price of 162.80 pence per Ordinary Share. Duncan Ball now holds 509,581 Ordinary Shares in the Company.
· On 19 May 2020, Frank Schramm sold 219,240 ordinary shares in the Company ("Ordinary Shares") at an average price of 162.80 pence per Ordinary Share. Frank Schramm now holds 500,000 Ordinary Shares in the Company.
The sale of these shares is being undertaken to pay tax and for personal portfolio planning purposes.
Together the Co-CEOs now hold 1,009,581 shares in the Company, which is approximately 200% of their current salaries, and remain totally committed to the long term success of BBGI.
The Supervisory Board of BBGI has approved these transactions and believes there continues to be strong alignment between the Management Board and shareholders as a result of the existing remuneration structure.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Director / PDMR Shareholding
1.
Details of the person discharging managerial responsibilities/person closely associated
a.
Name
Duncan Ball
2.
Reason for the notification
a.
Position / Status
Management Board Director / Co-CEO
b.
Initial Notification / Amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
BBGI SICAV S.A.
b.
LEI
5299 00CV 0RWC OP5Y HK95
4.
Details of the transaction(s):
[section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted]
a.
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares - No Par Value
ISIN - LU0686550053
b.
Nature of the transaction
Sale of shares
c.
Price(s) and volume(s)
| Price | Volume | Total |
| £1.628 | 250,000 | £407,000.00 |
d.
Aggregated information
- Aggregated volume
- Price
-Total Value
As in 4 c) above
e.
Date of the transaction
19 May 2020
f.
Place of the transaction
London Stock Exchange
Director / PDMR Shareholding
1.
Details of the person discharging managerial responsibilities/person closely associated
a.
Name
Frank Schramm
2.
Reason for the notification
a.
Position / Status
Management Board Director / Co-CEO
b.
Initial Notification / Amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
BBGI SICAV S.A.
b.
LEI
5299 00CV 0RWC OP5Y HK95
4.
Details of the transaction(s):
[section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted]
a.
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares - No Par Value
ISIN - LU0686550053
b.
Nature of the transaction
Sale of shares
c.
Price(s) and volume(s)
| Price | Volume | Total |
| £1.628 | 219,240 | £356,922.72 |
d.
Aggregated information
- Aggregated volume
- Price
-Total Value
As in 4 c) above
e.
Date of the transaction
19 May 2020
f.
Place of the transaction
London Stock Exchange
For further information, please contact:
BBGI SICAV S.A. +352 26 34 79-1
Duncan Ball
Frank Schramm
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHALMBTMTJBTPM